<DOC>
	<DOCNO>NCT01437800</DOCNO>
	<brief_summary>Objective : The purpose study evaluate oral bioavailability combination Glimepiride/ extend release Metformin ( GLI/METXR ) ( 4/850mg ) healthy Mexican volunteer . Methods : A prospective , longitudinal , open label , non randomize study , perform , 24 volunteer administrate single oral dose GLI/METXR ( 4/850 mg ) . Blood sample collect 30 hour . Plasma concentration drug measure use high-performance liquid chromatography ( HPLC ) . Plasma concentration-time curve plot volunteer , pharmacokinetic parameter ( PK ) calculate . Adverse event determine use clinical laboratory test result , throughout study .</brief_summary>
	<brief_title>BIOAVAILABILITY OF GLI/METXR ( 4/850 mg )</brief_title>
	<detailed_description />
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy Mexican volunteer , consider healthy accord standard screening assessment Aged 18 50 year old Body mass index ( BMI ) 18 27.5 Those history evidence cardiovascular , renal , hepatic , gastrointestinal , neurologic , muscular , metabolic , hematologic abnormality Any acute chronic disease Any drug allergy female volunteer positive urinary pregnancy test breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>DM2</keyword>
	<keyword>glimepiride</keyword>
	<keyword>metformin extend release</keyword>
</DOC>